Proxibarbital (Ipronal) is a barbiturate derivative synthesized in 1956. It has anti-anxiety properties and is, in contrast to most barbiturates, almost without hypnotic action.[1]
Clinical data | |
---|---|
Other names | Proxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
ECHA InfoCard | 100.018.004 |
Chemical and physical data | |
Formula | C10H14N2O4 |
Molar mass | 226.232 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
It was also used in the treatment of migraine headaches in a similar manner to butalbital.[2]
Valofane isomerises to Proxibarbal in vivo.
{{cite book}}
: CS1 maint: location missing publisher (link)